MLM Martin Marietta Materials, Inc.
Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy-side building materials to the construction industry in the United States and internationally. It operates through East Group and West Group segments. The company offers crushed stone, sand, and gravel products; ready mixed concrete and asphalt; and paving products and services for use in the infrastructure projects, and nonresidential and residential construction projects, as well as in the railroad, agricultural, utility, and environmental industries. It also produces magnesia-based chemicals products, and dolomitic lime primarily to customers for steel production and soil stabilization. Its chemical products are used in flame retardants, wastewater treatment, pulp and paper production, and other applications. The company was founded in 1939 and is based in Raleigh, North Carolina.…
Industry Peers
Building MaterialsKey Statistics
About Martin Marietta Materials (NYSE: MLM)
›
Martin Marietta Materials (NYSE: MLM) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Building Materials industry, part of the Basic Materials sector, and reports about 9,600 employees.
The shares were at 506.75 USD on 19 November 2026, down 15.6% over 52 weeks. Its 52-week range is 464.92 USD to 710.97 USD: the price is 28.7% below the high and 9.0% above the low.
At a market capitalisation of 36.04B USD, it trades at 37.8 times trailing earnings and 28.5 times forward earnings. The median trailing P/E of its 20 largest Building Materials peers is 17.5, a premium of 116% for MLM. It pays a dividend yielding 0.65% (it pays out 25% of its earnings), against a median of 1.59% among the dividend payers in that peer group.
Martin Marietta Materials reports return on equity of 11.3%, an operating margin of 20.2% and revenue up 28.3% year over year.
Its debt exceeds its cash by 13.11B USD, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 24 analysts cover the stock, with an average rating of Buy; their mean price target of 626.00 USD is 23.5% above the current price. The next earnings report is expected on 10 February 2027.